Study
|
Location
|
Population age (year)
|
Indication
|
Symptom severity
|
N
|
N of arms
|
Omalizumab
dose (SC)
|
Control
|
Intervention Duration
|
Casale, 199726
|
USA |
18-66 |
ragweed SAR |
1-2 |
240 |
4 |
0.15 mg/kg |
placebo |
12 weeks |
Adelroth, 200015
|
Scandinavia |
17-66 |
birch SAR |
NR |
251 |
2 |
300 mg |
placebo |
8 weeks |
Casale, 200127
|
USA |
12-75 |
ragweed SAR |
2-3 |
536 |
4 |
50-300 mg |
placebo |
9 weeks |
Kuehr, 200210
|
Germany |
6-17 |
birch, grass SAR |
NR |
225 |
4 |
0.016 mg/kg/IgE |
placebo |
24 weeks |
Chervinsky, 200316
|
USA |
12-70 |
mite, dog, cat PAR |
2-3 |
289 |
2 |
0.016 mg/kg/IgE |
placebo |
16 weeks |
Vingola, 200428
|
NR |
12-75 |
PAA & PAR |
2-3 |
405 |
2 |
0.016 mg/kg/IgE |
placebo |
28 weeks |
Casale, 200621
|
USA |
18-50 |
ragweed SAR |
|
159 |
4 |
0.016 mg/kg/IgE |
placebo |
21 weeks |
Okubo, 200613
|
Japan |
20-64 |
cedar SAR |
2-3 |
100 |
2 |
150-375 mg |
placebo |
12 weeks |
Nagakura, 200712
|
Japan |
20-64 |
cedar SAR |
2-3 |
308 |
2 |
0.016 mg/kg/IgE |
suplatast tosilate |
12 weeks |
Kopp, 200911
|
Germany |
11-46 |
SAA & SAR |
NR |
140 |
2 |
0.016 mg/kg/IgE |
placebo |
18 weeks |
Kamin, 201022
|
Germany |
children |
birch, grass SARC |
NR |
221 |
4 |
0.016 mg/kg/IgE |
placebo |
24 weeks |
Okubo, 2020¥14
|
Japan |
12-75 |
cedar SAR |
3 |
337 |
2 |
75-600 mg |
placebo* |
12 weeks |